Ultrasound biopsy to stage lung cancer before SBRT
Part of Cancer, Lungs & breathing clinical trials.
This trial looks at using a scope with an ultrasound tip (EBUS-TBNA) to take small tissue samples from lymph nodes to figure out the cancer stage before stereotactic body radiotherapy (SBRT). The goal is to help confirm how far the cancer has spread so SBRT can be planned appropriately.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Have confirmed non-small cell lung cancer and need this ultrasound-guided biopsy for lymph node staging before SBRT
- Have stage T1–2 lung cancer with no sign of distant metastasis (spread to other organs)
- Be able to do the procedure safely (your doctors think you can tolerate bronchoscopy) and have an illness/activity level score of 0–2
- Must have had or need CT and PET scans for staging, and you cannot have surgery (either not medically safe or you refused surgery)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks whether it’s practical to do gene (DNA) testing on samples taken during EBUS-TBNA, a common breathing-tube biopsy used to stage lung cancer. If it works well, it could make genetic testing faster and easier for people with lung cancer.
This study compares two ways to get a larger tissue sample from lymph nodes in the chest after a first small test confirmed cancer. The goal is to see which method provides better material for detailed genetic testing (next generation sequencing) that can guide treatment choices.
This study checks tiny pieces of DNA from a sample taken during a breathing-tube biopsy (EBUS-TBNA) to better identify certain lung cancer changes. It may help doctors learn more about the type of lung cancer and, in some cases, why targeted treatments stop working.
This study checks lymph nodes in the chest (using a camera-guided test) in people with advanced non-small cell lung cancer who are getting curative-intent radiation. The trial may help doctors better confirm how far the cancer has spread and guide the best radiation treatment plan.
This trial is for people who are scheduled for a lung cancer biopsy (EBUS-TBNA) because doctors suspect non-small cell lung cancer (NSCLC) has spread to lymph nodes. It will test leftover fluid from the biopsy to see if it improves cancer detection. If your biopsy is negative but you still need surgery to remove lymph nodes, you can help us learn more about this new test.
This trial uses a special ultrasound-guided procedure to take tissue samples from swollen lymph nodes in the chest. It aims to improve diagnosis for people who already need a bronchoscopy.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.